NCT04767776View on ClinicalTrials.gov

Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

September 26, 2022

Study Completion Date

November 4, 2022

Conditions
Healthy
Interventions
DRUG

Rivaroxaban

rivaroxaban 40 mg/day (1 day).

DRUG

Activated charcoal

Activated charcoal 2 hours after rivaroxaban administration (1 day).

Trial Locations (1)

42000

CHU de SAINT-ETIENNE, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT04767776 - Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics. | Biotech Hunter | Biotech Hunter